Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0KVQCJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ABBV-787
|
|||||
| Synonyms |
ABBV-787; ABBV787; ABBV 787
Click to Show/Hide
|
|||||
| Organization |
ABBVIE INC.
|
|||||
| Drug Status |
Phase 1 (Terminated)
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Myeloid cell surface antigen CD33 (CD33)
|
Antigen Info | ||||
| Payload Name |
BET degrader
|
Payload Info | ||||
| Therapeutic Target |
BET
|
Target Info | ||||
| Linker Name |
undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
